tiprankstipranks
Lucira Health (LHDX)
NASDAQ:LHDX
US Market
Holding LHDX?
Track your performance easily

Lucira Health (LHDX) Income Statement

0 Followers

Lucira Health Income Statement

Last quarter (Q ), Lucira Health's total revenue was $34.39M, an increase of 129.63% from the same quarter last year. In Q, Lucira Health's net income was $-126.86M. See Lucira Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 212.13M$ 93.06M$ 269.00K$ 0.00$ 0.00
Cost of Revenue
$ 251.16M$ 82.83M$ 1.94M$ 0.00-
Gross Profit
$ -39.02M$ 10.22M$ -1.67M$ 0.00-
Operating Expense
$ 102.65M$ 74.76M$ 28.11M$ 7.70M$ 6.16M
Operating Income
$ -141.67M$ -64.54M$ -29.78M$ -7.70M$ -6.16M
Net Non Operating Interest Income Expense
$ -1.57M$ 11.00K$ -53.00K$ -90.00K$ -190.00K
Other Income Expense
-$ -281.00K$ -7.51M$ -674.00K$ -183.00K
Pretax Income
$ -143.24M$ -64.81M$ -37.35M$ -8.47M$ -6.54M
Tax Provision
$ 16.00K$ 17.00K$ 0.00--
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -143.28M$ -64.83M$ -37.35M$ -8.47M$ -6.54M
Basic EPS
$ -3.56$ -1.86$ -1.04$ -1.07$ -0.83
Diluted EPS
$ -3.58$ -1.86$ -1.04$ -1.07$ -0.83
Basic Average Shares
$ 158.91M$ 34.77M$ 35.87M$ 7.91M$ 7.91M
Diluted Average Shares
$ 161.01M$ 34.77M$ 35.87M$ 7.91M$ 7.91M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 353.81M$ 157.59M$ 30.05M$ 7.70M$ 6.16M
Net Income From Continuing And Discontinued Operation
$ -143.28M$ -64.83M$ -37.35M$ -8.47M$ -6.54M
Normalized Income
$ -143.28M$ -64.62M$ -29.83M$ -7.79M$ -6.35M
Interest Expense
$ 2.31M$ 3.00K$ 53.00K$ 90.00K$ 190.00K
EBIT
$ -141.20M$ -64.81M$ -37.30M$ -8.38M$ -6.35M
EBITDA
$ -134.68M$ -61.14M$ -37.02M$ -8.09M$ -6.10M
Currency in USD

Lucira Health Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis